The ARKK fund bought 69,011 shares of CRISPR Therapeutics AG and 142,713 shares of Beam Therapeutics Inc. Based on the last ...

Sea SE has outperformed the market over the past 5 years by 4.95% on an annualized basis producing an average annual return ...

Buying $100 In RTX: If an investor had bought $100 of RTX stock 5 years ago, it would be worth $204.05 today based on a price ...

Guidewire Software GWRE -5.39% Get Free Report has outperformed the market over the past 10 years by 3.2% on an annualized ...

Casella Waste Systems CWST has outperformed the market over the past 5 years by 6.39% on an annualized basis producing an ...

Buying $100 In MASI: If an investor had bought $100 of MASI stock 10 years ago, it would be worth $417.46 today based on a ...

Interactive Brokers Group IBKR has outperformed the market over the past 15 years by 5.53% on an annualized basis producing ...

Roche's trontinemab data showed dose-dependent amyloid reduction in Alzheimer's patients, while its Elecsys pTau181 test aims ...

Gartner IT has outperformed the market over the past 10 years by 7.09% on an annualized basis producing an average annual ...

Analyst Vivek Arya met with optical and networking component vendors at OFC conference. Optical innovations drive growth, CPO ...